Zimmer Biomet Holdings, Inc. (ZBH) EV/EBITDA Ratio: 11.00x
Is Zimmer Biomet Holdings, Inc.’s EV/EBITDA ratio high or low?
Zimmer Biomet Holdings, Inc.'s EV/EBITDA ratio of 11.00x is 30% below its 5-year average of 15.74x, near the low end of its 5-year range (10.03x–24.54x).
As of Saturday, June 20, 2026. 0.73% below its 12-month average of 11.08x.
ZBH EV/EBITDA Ratio Chart
ZBH Average EV/EBITDA Ratio Chart
ZBH Current vs Average EV/EBITDA Ratio Chart
ZBH EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
11.00x
EV/EBITDA RATIO AVG TTM
11.08x
EV/EBITDA RATIO AVG 3Y
12.87x
EV/EBITDA RATIO AVG 5Y
15.74x
EV/EBITDA RATIO AVG 10Y
17.32x
EV/EBITDA RATIO AVG 15Y
16.17x
EV/EBITDA RATIO AVG 20Y
14.10x
CURRENT VS TTM AVG
-0.73%
CURRENT VS 3Y AVG
-14.50%
CURRENT VS 5Y AVG
-30.13%
CURRENT VS 10Y AVG
-36.49%
CURRENT VS 15Y AVG
-31.98%
CURRENT VS 20Y AVG
-21.97%
ZBH Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. (ZBH) | $17.02B | 11.00x | 11.08x | 12.87x | 15.74x |
| Hologic, Inc. (HOLX)vs › | $16.97B | 17.28x | 15.01x | 15.35x | 12.41x |
| DaVita Inc. (DVA)vs › | $13.34B | 9.93x | 9.09x | 9.40x | 9.39x |
| Medpace Holdings, Inc. (MEDP)vs › | $13.14B | 21.33x | 26.05x | 25.79x | 25.60x |
| Solventum Corporation (SOLV)vs › | $13.06B | 6.45x | 9.99x | 10.26x | 10.26x |
| Labcorp Holdings Inc. (LH)vs › | $20.98B | 13.32x | 14.65x | 14.58x | 11.74x |
| Align Technology, Inc. (ALGN)vs › | $13.04B | 13.29x | 13.06x | 20.16x | 25.78x |
| The Cooper Companies, Inc. (COO)vs › | $12.85B | 17.52x | 16.00x | 20.09x | 21.89x |
| United Therapeutics Corporation (UTHR)vs › | $22.78B | 14.15x | 11.68x | 10.11x | 11.31x |
| Revvity, Inc. (RVTY)vs › | $11.16B | 17.70x | 17.09x | 19.85x | 18.23x |
EV/EBITDA vs. its own history
At 11.0, EV/EBITDA is cheaper than usual, sitting higher than 30% of its 20-year history.
20-year low
5.0
median
13.3
20-year high
44.9
Zimmer Biomet Holdings, Inc. EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Zimmer Biomet Holdings, Inc. EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The EV/EBITDA ratio for ZBH stock is 11.00x.
- Is Zimmer Biomet Holdings, Inc.'s EV/EBITDA ratio high or low?
- Zimmer Biomet Holdings, Inc.'s EV/EBITDA ratio of 11.00x is 30% below its 5-year average of 15.74x, near the low end of its 5-year range (10.03x–24.54x).
- What is the TTM average EV/EBITDA ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The TTM average EV/EBITDA ratio for ZBH stock is 11.08x.
- What is the 3Y average EV/EBITDA ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 3Y average EV/EBITDA ratio for ZBH stock is 12.87x.
- What is the 5Y average EV/EBITDA ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 5Y average EV/EBITDA ratio for ZBH stock is 15.74x.
- What is the 10Y average EV/EBITDA ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 10Y average EV/EBITDA ratio for ZBH stock is 17.32x.
- What is the 15Y average EV/EBITDA ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 15Y average EV/EBITDA ratio for ZBH stock is 16.17x.
- What is the 20Y average EV/EBITDA ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 20Y average EV/EBITDA ratio for ZBH stock is 14.10x.
Zimmer Biomet Holdings, Inc. EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-18 | 11.00x |
| 2026-06-17 | 10.93x |
| 2026-06-16 | 11.12x |
| 2026-06-15 | 11.03x |
| 2026-06-12 | 11.06x |
| 2026-06-11 | 10.93x |
| 2026-06-10 | 11.02x |
| 2026-06-09 | 11.15x |
| 2026-06-08 | 10.94x |
| 2026-06-05 | 10.95x |
| 2026-06-04 | 10.89x |
| 2026-06-03 | 10.74x |
| 2026-06-02 | 10.63x |
| 2026-06-01 | 10.56x |
| 2026-05-29 | 10.50x |
| 2026-05-28 | 10.54x |
| 2026-05-27 | 10.52x |
| 2026-05-26 | 10.69x |
| 2026-05-22 | 10.78x |
| 2026-05-21 | 10.77x |
| 2026-05-20 | 10.77x |
| 2026-05-19 | 10.83x |
| 2026-05-18 | 10.75x |
| 2026-05-15 | 10.62x |
| 2026-05-14 | 10.53x |
| 2026-05-13 | 10.54x |
| 2026-05-12 | 10.59x |
| 2026-05-11 | 10.26x |
| 2026-05-08 | 10.50x |
| 2026-05-07 | 10.59x |
| 2026-05-06 | 10.55x |
| 2026-05-05 | 10.56x |
| 2026-05-04 | 10.53x |
| 2026-05-01 | 10.55x |
| 2026-04-30 | 10.49x |
| 2026-04-29 | 10.28x |
| 2026-04-28 | 10.52x |
| 2026-04-27 | 11.40x |
| 2026-04-24 | 11.28x |
| 2026-04-23 | 11.38x |
| 2026-04-22 | 11.44x |
| 2026-04-21 | 11.40x |
| 2026-04-20 | 11.65x |
| 2026-04-17 | 11.59x |
| 2026-04-16 | 11.59x |
| 2026-04-15 | 11.54x |
| 2026-04-14 | 11.75x |
| 2026-04-13 | 11.64x |
| 2026-04-10 | 11.44x |
| 2026-04-09 | 11.44x |
| 2026-04-08 | 11.43x |
| 2026-04-07 | 11.29x |
| 2026-04-06 | 11.25x |
| 2026-04-02 | 11.24x |
| 2026-04-01 | 11.26x |
| 2026-03-31 | 11.20x |
| 2026-03-30 | 11.04x |
| 2026-03-27 | 11.04x |
| 2026-03-26 | 11.09x |
| 2026-03-25 | 10.95x |
| 2026-03-24 | 10.84x |
| 2026-03-23 | 10.97x |
| 2026-03-20 | 10.97x |
| 2026-03-19 | 11.15x |
| 2026-03-18 | 11.08x |
| 2026-03-17 | 11.39x |
| 2026-03-16 | 11.46x |
| 2026-03-13 | 11.45x |
| 2026-03-12 | 11.40x |
| 2026-03-11 | 11.50x |
| 2026-03-10 | 11.32x |
| 2026-03-09 | 11.46x |
| 2026-03-06 | 11.53x |
| 2026-03-05 | 11.47x |
| 2026-03-04 | 11.68x |
| 2026-03-03 | 11.88x |
| 2026-03-02 | 12.01x |
| 2026-02-27 | 11.92x |
| 2026-02-26 | 12.15x |
| 2026-02-25 | 12.04x |
| 2026-02-24 | 12.05x |
| 2026-02-23 | 12.01x |
| 2026-02-20 | 11.95x |
| 2026-02-19 | 11.99x |
| 2026-02-18 | 11.08x |
| 2026-02-17 | 10.99x |
| 2026-02-13 | 10.93x |
| 2026-02-12 | 10.82x |
| 2026-02-11 | 10.86x |
| 2026-02-10 | 10.51x |
| 2026-02-09 | 10.37x |
| 2026-02-06 | 10.38x |
| 2026-02-05 | 10.29x |
| 2026-02-04 | 10.23x |
| 2026-02-03 | 10.07x |
| 2026-02-02 | 10.08x |
| 2026-01-30 | 10.15x |
| 2026-01-29 | 10.06x |
| 2026-01-28 | 10.03x |
| 2026-01-27 | 10.06x |
| 2026-01-26 | 10.17x |
| 2026-01-23 | 10.11x |
| 2026-01-22 | 10.19x |
| 2026-01-21 | 10.10x |
| 2026-01-20 | 10.12x |
| 2026-01-16 | 10.17x |
| 2026-01-15 | 10.29x |
| 2026-01-14 | 10.33x |
| 2026-01-13 | 10.25x |
| 2026-01-12 | 10.51x |
| 2026-01-09 | 10.63x |
| 2026-01-08 | 10.73x |
| 2026-01-07 | 10.62x |
| 2026-01-06 | 10.79x |
| 2026-01-05 | 10.61x |
| 2026-01-02 | 10.39x |
| 2025-12-31 | 10.39x |
| 2025-12-30 | 10.46x |
| 2025-12-29 | 10.44x |
| 2025-12-26 | 10.46x |
| 2025-12-24 | 10.41x |
| 2025-12-23 | 10.34x |
| 2025-12-22 | 10.38x |
| 2025-12-19 | 10.32x |
| 2025-12-18 | 10.43x |
| 2025-12-17 | 10.52x |
| 2025-12-16 | 10.47x |
| 2025-12-15 | 10.60x |
| 2025-12-12 | 10.52x |
| 2025-12-11 | 10.60x |
| 2025-12-10 | 10.65x |
| 2025-12-09 | 10.58x |
| 2025-12-08 | 10.62x |
| 2025-12-05 | 10.75x |
| 2025-12-04 | 10.66x |
| 2025-12-03 | 10.65x |
| 2025-12-02 | 10.74x |
| 2025-12-01 | 10.79x |
| 2025-11-28 | 11.02x |
| 2025-11-26 | 11.02x |
| 2025-11-25 | 10.98x |
| 2025-11-24 | 10.69x |
| 2025-11-21 | 10.57x |
| 2025-11-20 | 10.31x |
| 2025-11-19 | 10.35x |
| 2025-11-18 | 10.31x |
| 2025-11-17 | 10.28x |
| 2025-11-14 | 10.38x |
| 2025-11-13 | 10.44x |
| 2025-11-12 | 10.39x |
| 2025-11-11 | 10.27x |
| 2025-11-10 | 10.29x |
| 2025-11-07 | 10.27x |
| 2025-11-06 | 10.27x |
| 2025-11-05 | 10.19x |
| 2025-11-04 | 12.08x |
| 2025-11-03 | 11.79x |
| 2025-10-31 | 11.85x |
| 2025-10-30 | 11.76x |
| 2025-10-29 | 11.77x |
| 2025-10-28 | 11.90x |
| 2025-10-27 | 12.07x |
| 2025-10-24 | 12.06x |
| 2025-10-23 | 12.07x |
| 2025-10-22 | 12.15x |
| 2025-10-21 | 12.03x |
| 2025-10-20 | 12.04x |
| 2025-10-17 | 11.97x |
| 2025-10-16 | 11.79x |
| 2025-10-15 | 11.74x |
| 2025-10-14 | 11.66x |
| 2025-10-13 | 11.37x |
| 2025-10-10 | 11.34x |
| 2025-10-09 | 11.57x |
| 2025-10-08 | 11.66x |
| 2025-10-07 | 11.72x |
| 2025-10-06 | 11.70x |
| 2025-10-03 | 11.87x |
| 2025-10-02 | 11.73x |
| 2025-10-01 | 11.70x |
| 2025-09-30 | 11.67x |
| 2025-09-29 | 11.65x |
| 2025-09-26 | 11.65x |
| 2025-09-25 | 11.53x |
| 2025-09-24 | 11.71x |
| 2025-09-23 | 11.82x |
| 2025-09-22 | 11.95x |
| 2025-09-19 | 11.81x |
| 2025-09-18 | 11.82x |
| 2025-09-17 | 11.79x |
| 2025-09-16 | 11.72x |
| 2025-09-15 | 11.88x |
| 2025-09-12 | 12.07x |
| 2025-09-11 | 12.17x |
| 2025-09-10 | 12.00x |
| 2025-09-09 | 12.13x |
| 2025-09-08 | 12.21x |
| 2025-09-05 | 12.30x |
| 2025-09-04 | 12.21x |
| 2025-09-03 | 12.24x |
| 2025-09-02 | 12.24x |
| 2025-08-29 | 12.33x |
| 2025-08-28 | 12.24x |
| 2025-08-27 | 12.39x |
| 2025-08-26 | 12.46x |
| 2025-08-25 | 12.44x |
| 2025-08-22 | 12.47x |
| 2025-08-21 | 12.18x |
| 2025-08-20 | 12.30x |
| 2025-08-19 | 12.17x |
| 2025-08-18 | 12.02x |
| 2025-08-15 | 12.04x |
| 2025-08-14 | 11.98x |
| 2025-08-13 | 12.08x |
| 2025-08-12 | 11.96x |
| 2025-08-11 | 11.80x |
| 2025-08-08 | 11.73x |
| 2025-08-07 | 11.66x |
| 2025-08-06 | 10.45x |
| 2025-08-05 | 10.53x |
| 2025-08-04 | 10.56x |
| 2025-08-01 | 10.40x |
| 2025-07-31 | 10.49x |
| 2025-07-30 | 10.64x |
| 2025-07-29 | 10.78x |
| 2025-07-28 | 10.87x |
| 2025-07-25 | 11.01x |
| 2025-07-24 | 10.95x |
| 2025-07-23 | 10.99x |
| 2025-07-22 | 10.92x |
| 2025-07-21 | 10.58x |
| 2025-07-18 | 10.63x |
| 2025-07-17 | 10.78x |
| 2025-07-16 | 10.72x |
| 2025-07-15 | 10.70x |
| 2025-07-14 | 10.69x |
| 2025-07-11 | 10.68x |
| 2025-07-10 | 10.80x |
| 2025-07-09 | 10.80x |
| 2025-07-08 | 10.65x |
| 2025-07-07 | 10.57x |
| 2025-07-03 | 10.67x |
| 2025-07-02 | 10.65x |
| 2025-07-01 | 10.70x |
| 2025-06-30 | 10.46x |
| 2025-06-27 | 10.48x |
| 2025-06-26 | 10.50x |
| 2025-06-25 | 10.59x |
| 2025-06-24 | 10.55x |
| 2025-06-23 | 10.48x |
| 2025-06-20 | 10.46x |
| 2025-06-18 | 10.40x |
| 2025-06-17 | 10.37x |
| 2025-06-16 | 10.54x |
| 2025-06-13 | 10.46x |
| 2025-06-12 | 10.63x |
| 2025-06-11 | 10.72x |
| 2025-06-10 | 10.78x |
| 2025-06-09 | 10.60x |
| 2025-06-06 | 10.56x |
Showing the most recent 260 of 5,032 data points. The chart above shows the full history.
Related Metrics
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ivan Tornos